Methylphenidate-Type Psychostimulants Can Reduce Cancer-Related Fatigue

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 26, 2026.

via HealthDay

TUESDAY, May 26, 2026 -- Pharmacological interventions, notably methylphenidate (MPH)-type psychostimulants, reduce cancer-related fatigue (CRF), according to a review published in the May issue of the Journal of the National Comprehensive Cancer Network.

Bruno Almeida Costa, M.D., from The University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a systematic literature review and meta-analysis to examine the efficacy and safety of MPH and dexmethylphenidate (d-MPH) in managing CRF. Nine randomized controlled trials met the inclusion criteria, with 823 adults with advanced cancer or receiving active cancer-directed therapy.

The researchers found that MPH/d-MPH monotherapy (MPH-equivalent dose range, 5 to 100 mg/day) yielded significant improvements in fatigue score compared with placebo, as measured by the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F; mean difference, 2.43), self-rated 0 to 10 scales (mean difference, −1.52), and any validated scale (standardized mean difference, 0.38). A temporal gradient was seen in FACIT-F improvements, exceeding the 3-point threshold for clinical meaningfulness by five weeks (mean difference, 3.56) and increasing further by eight or more weeks (mean difference, 3.89). There were no statistically significant differences seen in the odds of key treatment-emergent adverse events.

"What makes this finding particularly noteworthy is the time dimension: the benefit isn't fully apparent in the first couple of weeks, but by around five weeks, it reaches a level that genuinely matters in terms of patients' daily energy and function," Costa said in a statement. "For people dealing with a symptom that can be profoundly disabling, that is a meaningful contribution."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-27 03:04

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords